君实生物(01877.HK)第三季度净亏损约为1.83亿元

Core Insights - Junshi Biosciences (01877.HK) reported a revenue of approximately RMB 637 million for Q3 2025, representing a year-on-year increase of 31.4% [1] - The company recorded a net loss of approximately RMB 183 million, with a basic earnings per share of -0.18 yuan [1] - For the first three quarters, the revenue was approximately RMB 1.805 billion, reflecting a year-on-year growth of 42.06% [1] - The net loss for the first three quarters amounted to RMB 596 million [1]